NCT03907709 is a clinical trial of In-Home Addiction Treatment Program in Substance Use Disorders, sponsored by In-Home Addiction Treatment Institute, Inc..

Who is sponsoring NCT03907709?

NCT03907709 is sponsored by In-Home Addiction Treatment Institute, Inc..

What drugs are being tested in NCT03907709?

Interventions in NCT03907709: In-Home Addiction Treatment Program.

What condition does NCT03907709 study?

NCT03907709 studies Substance Use Disorders.

Is NCT03907709 still recruiting?

NCT03907709 is currently suspended. Last updated 7 August 2019.

Last reviewed 2019-08-07 · How we verify

NCT03907709

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of In-Home Addiction Treatment for First Responders

Suspended Last updated 7 August 2019

What this trial tests

trial testing In-Home Addiction Treatment Program in Substance Use Disorders in 15 participants. Suspended.

Timeline

8 April 2019

Primary endpoint
28 May 2020

28 July 2020

Quick facts

Lead sponsor	In-Home Addiction Treatment Institute, Inc.
Status	Suspended
Study type	OBSERVATIONAL
Enrollment	15
Start date	8 April 2019
Primary completion	28 May 2020
Estimated completion	28 July 2020
Sites	1 location across United States

Drugs / interventions tested

In-Home Addiction Treatment Program

Conditions studied

Substance Use Disorders — all drugs for Substance Use Disorders →

Sponsor

In-Home Addiction Treatment Institute, Inc.

Who can join

Adults 18 to 75, any sex, with Substance Use Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective analysis to evaluate impact of an in-home addiction treatment program on first responders with substance use disorder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Substance Use Disorders

Currently open trials in the same condition.

NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
NCT07529327 — Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups an · NA · recruiting
NCT07281261 — tAN for Substance Use Disorder · NA · recruiting
NCT07210268 — Temporal Interference Methods for Addiction Treatment · NA · recruiting
NCT07146633 — Efficacy of an EMDR App for PTSD and SUD · NA · recruiting

Other In-Home Addiction Treatment Institute, Inc. trials

Trials by the same sponsor.

NCT03902171 — Soberlink Within In-Home Addiction Treatment Program · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03907709 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by In-Home Addiction Treatment Institute, Inc.
Last refreshed: 7 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03907709.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing